Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Point mutations in the presenilin-1 gene (PS1) are a major cause of familial Alzheimer's disease. They result in a selective increase in the production of the amyloidogenic peptide amyloid-beta(1-42) by proteolytic processing of the amyloid precursor protein (APP). Here we investigate whether PS1 is also involved in normal APP processing in neuronal cultures derived from PS1-deficient mouse embryos. Cleavage by alpha- and beta-secretase of the extracellular domain of APP was not affected by the absence of PS1, whereas cleavage by gamma-secretase of the transmembrane domain of APP was prevented, causing carboxyl-terminal fragments of APP to accumulate and a fivefold drop in the production of amyloid peptide. Pulse-chase experiments indicated that PS1 deficiency specifically decreased the turnover of the membrane-associated fragments of APP. As in the regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor, PS1 appears to facilitate a proteolytic activity that cleaves the integral membrane domain of APP. Our results indicate that mutations in PS1 that manifest clinically cause a gain of function and that inhibition of PS1 activity is a potential target for anti-amyloidogenic therapy in Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ is produced by sequential β- and γ-secretase proteolytic cleavage of the amyloid precursor protein (APP) [11–17].”
From Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure (2018) · cites this paper as [13]
In the citing paper
“The three major APOE variants, APOE2, APOE3, and APOE4, differ from each other at two amino acid positions, 112 and 158, and modulate AD risk. E3 is the most common APOE variant and is considered neutral with regards to AD risk, while E4 alleles elevate AD risk and E2 reduces AD risk12,13.”
From APOE3 - R136S mutation confers resilience against tau pathology via cGAS-STING-IFN inhibition (2024) · cites this paper as [12]
In the citing paper
“knocking out the gene results in decreased production of both βA4(1-40) and (1-42) amyloid peptides (De Strooper et al. 1998).”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
In the citing paper
“Mutations of presenilin 1 (PS1) causing Alzheimer's disease selectively increase the secretion of the amyloidogenic βA4(1-42)”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
In the citing paper
“As β- (and α-) clipping was virtually normal in neurons derived from those animals, the effect on APP processing is confined to γ-secretase activities (De Strooper et al. 1998).”
From Presenilin 1 Controls γ-Secretase Processing of Amyloid Precursor Protein in Pre-Golgi Compartments of Hippocampal Neurons (1999) · cites this paper as De Strooper et al. 1998
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834 · cited 1×
“As in the regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription facto”
BackgroundScheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921 · cited 1×
“This was confirmed using antibodies against amino-acid residues 595–612 (R1736”
MethodAmyloid, the presenilins and Alzheimer’s disease
Hardy, J. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01030-2 · Cited by 1,370
Citron, M., Westaway, D., Xia, W., Carlson, G., Diehl, T., Levesque, G., Johnson-wood, K., Lee, M., Seubert, P., Davis, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0197-67 · Cited by 1,271
Skeletal and CNS Defects in Presenilin-1-Deficient Mice
Shen, J., Bronson, R. T., Chen, D. F., Xia, W., Selkoe, D. J., & Tonegawa, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80244-5 · Cited by 959
Presenilin 1 is required for Notch 1 and Dll1 expression in the paraxial mesoderm
Wong, P. C., Zheng, H., Chen, H., Becher, M. W., Sirinathsinghji, D. J. S., Trumbauer, M. E., Chen, H. Y., Price, D. L., Van der Ploeg, L. H. T., & Sisodia, S. S. (1997) · Nature · doi:10.1038/387288a0 · Cited by 711
Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides
Hartmann, T., Bieger, S. C., Brühl, B., Tienari, P. J., Ida, N., Allsop, D., Roberts, G. W., Masters, C. L., Dotti, C. G., Unsicker, K., et al. (1997) · Nature Medicine · doi:10.1038/nm0997-1016 · Cited by 709
Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide
Haass, C., & Selkoe, D. J. (1993) · Cell · doi:10.1016/0092-8674(93)90312-e · Cited by 686
Cited by
Items 601–700 of 1,008
Yu, G., Chen, F., Nishimura, M., Steiner, H., Tandon, A., Kawarai, T., Arawaka, S., Supala, A., Song, Y.-Q., Rogaeva, E., et al. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61517-6 · Cited by 70
Smit, T., Deshayes, N. A. C., Borchelt, D. R., Kamphuis, W., Middeldorp, J., & Hol, E. M. (2021) · Glia · doi:10.1002/glia.23981 · Cited by 71
Contribution of the Presenilins in the cell biology, structure and function of γ-secretase
Escamilla-Ayala, A., Wouters, R., Sannerud, R., & Annaert, W. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.02.005 · Cited by 65
Self-citationGadhave, K., Kumar, D., Uversky, V. N., & Giri, R. (2021) · Medicinal Research Reviews · doi:10.1002/med.21719 · Cited by 68
Activation of AMPK by GLP-1R agonists mitigates Alzheimer-related phenotypes in transgenic mice
Zhang, Y., Chen, H., Feng, Y., Liu, M., Lu, Z., Hu, B., Chen, L., Zhang, Y., Liu, J., Cai, F., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00869-3 · Cited by 75
“Subsequently, γ-secretase cleaves C99, leading to the release of Aβ and the CTFγ 5,6 .”
Influential(2010) · Europe PMC (PubMed Central)
Early calcium dysregulation in Alzheimer’s disease: setting the stage for synaptic dysfunction
Chakroborty, S., & Stutzmann, G. E. (2011) · Science China Life Sciences · doi:10.1007/s11427-011-4205-7 · Cited by 70
Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer’s disease
Yan, R., Fan, Q., Zhou, J., & Vassar, R. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.025 · Cited by 71
“…et al., 1999; Lin et al., 2000; Sinha et al., 1999; Vassar et al., 1999; Yan et al., 1999). γ-secretase is a complex composed mainly of four transmembrane proteins: presenilin-1 or -2, nicastrin, Aph1, and Pen2 (De Strooper et al., 1998; Francis et al., 2002; Li et al., 2000; Yu et al., 2000).”
Abou‐Abbass, H., Abou‐El‐Hassan, H., Bahmad, H. F., Zibara, K., Zebian, A., Youssef, R., Ismail, J. N., Zhu, R., Zhou, S., Dong, X., et al. (2016) · Electrophoresis · doi:10.1002/elps.201500585 · Cited by 79
Moechars, D., Lorent, K., & Leuven, F. V. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00599-5 · Cited by 78
Protein aggregates and dementia: is there a common toxicity?
Lovestone, S., & McLoughlin, D. M. (2002) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.152 · Cited by 82
Presenilin 1 Protein Directly Interacts with Bcl-2
Alberici, A., Moratto, D., Benussi, L., Gasparini, L., Ghidoni, R., Gatta, L. B., Finazzi, D., Frisoni, G. B., Trabucchi, M., Growdon, J. H., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30764 · Cited by 80
Mutations in APP have independent effects on Aβ and CTFγ generation
Hecimovic, S., Wang, J., Dolios, G., Martinez, M., Wang, R., & Goate, A. M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.04.018 · Cited by 70
“…Yan et al., 1999), while generation of the C-terminus of Ah involves an unusual intramembranous cleavage by a multi-protein g-secretase complex (De Strooper et al., 1998; Steiner et al., 1999). g-Secretase cleavage seems not to be site restricted since it generates Ah fragments of 37–43 amino…”
BackgroundDysregulated Wnt Signalling in the Alzheimer’s Brain
Aghaizu, N. D., Jin, H., & Whiting, P. J. (2020) · Brain Sciences · doi:10.3390/brainsci10120902 · Cited by 70
Kwart, D., Gregg, A., Scheckel, C., Murphy, E. A., Paquet, D., Duffield, M., Fak, J., Olsen, O., Darnell, R. B., & Tessier-Lavigne, M. (2019) · Neuron · doi:10.1016/j.neuron.2019.11.010 · Cited by 70
BACE2 distribution in major brain cell types and identification of novel substrates
Voytyuk, I., Mueller, S. A., Herber, J., Snellinx, A., Moechars, D., van Loo, G., Lichtenthaler, S. F., & De Strooper, B. (2018) · Life Science Alliance · doi:10.26508/lsa.201800026 · Cited by 71
Presenilin-mediated cleavage of APP regulates synaptotagmin-7 and presynaptic plasticity
Barthet, G., Jordà-Siquier, T., Rumi-Masante, J., Bernadou, F., Müller, U., & Mulle, C. (2018) · Nature Communications · doi:10.1038/s41467-018-06813-x · Cited by 69
γ-Secretase Inhibition and Modulation for Alzheimers Disease
Wolfe, M. S. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954767 · Cited by 79
Zhang, L., Song, L., & Parker, E. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8966 · Cited by 70
Romero‐Isart, N., Jensen, L. T., Zerbe, O., Winge, D. R., & Vašák, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205730200 · Cited by 74
Epigenetic Changes and Its Intervention in Age-Related Neurodegenerative Diseases
Murshid, N. M., Lubis, F. A., & Makpol, S. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00979-z · Cited by 69
Notchand the Awesome Power of Genetics
Greenwald, I. (2012) · Genetics · doi:10.1534/genetics.112.141812 · Cited by 77
“In the intervening time, Schroeter et al. (1998) and Struhl and Adachi (1998) had provided compelling evidence for the cleavage model, and De Strooper et al. (1998) had found that Presenilin was required for transmembrane cleavage of b-APP.”
BackgroundThe role of presenilin 1 during somite segmentation
Koizumi, K.-I., Nakajima, M., Yuasa, S., Saga, Y., Sakai, T., Kuriyama, T., Shirasawa, T., & Koseki, H. (2001) · Development · doi:10.1242/dev.128.8.1391 · Cited by 77
Novel therapeutic strategies provide the real test for the amyloid hypothesis of Alzheimer's disease
Dominguez, D. I., & Strooper, B. D. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02038-2 · Cited by 77
Shirotani, K., Tomioka, M., Kremmer, E., Haass, C., & Steiner, H. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.04.011 · Cited by 68
“PS is the catalytic subunit of γ-secretase (De Strooper et al., 1998; Li et al., 2000; Steiner et al., 2000; Wolfe et al., 1999), a protease complex, which, following a preceding cleavage by β-secretase, liberates Aβ from the β-amyloid precursor protein (APP).”
BackgroundZhao, L., Shey, M. R., Farnsworth, M., & Dailey, M. O. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103748200 · Cited by 69
Tamboli, I. Y., Prager, K., Thal, D. R., Thelen, K. M., Dewachter, I., Pietrzik, C. U., St. George-Hyslop, P., Sisodia, S. S., De Strooper, B., Heneka, M. T., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2635-08.2008 · Cited by 68
“Consis- tent with previous studies (De Strooper et al., 1998; Wolfe et al., 1999a; Wolfe et al., 1999b), we observed a strong accumulation of APP CTFs in PS-deficient cells and after inhibition of -secretase activity by DAPT (supplemental Fig.”
Wang, H., Megill, A., He, K., Kirkwood, A., & Lee, H.-K. (2012) · Neural Plasticity · doi:10.1155/2012/272374 · Cited by 59
Mutagenesis Mapping of the Presenilin 1 Calcium Leak Conductance Pore
Nelson, O., Supnet, C., Tolia, A., Horré, K., De Strooper, B., & Bezprozvanny, I. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.243063 · Cited by 66
Goiran, T., Duplan, E., Chami, M., Bourgeois, A., El Manaa, W., Rouland, L., Dunys, J., Lauritzen, I., You, H., Stambolic, V., et al. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.04.011 · Cited by 67
Apical Sorting of β-Secretase Limits Amyloid β-Peptide Production
Capell, A., Meyn, L., Fluhrer, R., Teplow, D. B., Walter, J., & Haass, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109119200 · Cited by 67
Xing, Y., & Higuchi, K. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00098-2 · Cited by 77
Winkler, E., Hobson, S., Fukumori, A., Dümpelfeld, B., Luebbers, T., Baumann, K., Haass, C., Hopf, C., & Steiner, H. (2009) · Biochemistry · doi:10.1021/bi801204g · Cited by 68
Tandon, A., & Fraser, P. E. (2002) · Genome biology · doi:10.1186/gb-2002-3-11-reviews3014 · Cited by 88
Parkin, E. T., Hussain, I., Karran, E. H., Turner, A. J., & Hooper, N. M. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721534.x · Cited by 67
Amyloid-β interrupts canonical Sonic hedgehog signaling by distorting primary cilia structure
Vorobyeva, A. G., & Saunders, A. J. (2018) · Cilia · doi:10.1186/s13630-018-0059-y · Cited by 67
Co-aggregation with Apolipoprotein E modulates the function of Amyloid-β in Alzheimer’s disease
Xia, Z., Prescott, E. E., Urbanek, A., Wareing, H. E., King, M. C., Olerinyova, A., Dakin, H., Leah, T., Barnes, K. A., Matuszyk, M. M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49028-z · Cited by 67
Pharmacology of epigenetics in brain disorders
Narayan, P., & Dragunow, M. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00526.x · Cited by 67
“The second cleavage is performed by g-secretase which is a PSEN (either PSEN1 or PSEN2)dependent enzyme (Citron et al., 1997; De Strooper et al., 1998), and produces the APP intracellular domain (AICD, also known as an APP C-terminal fragment, APP-CT) and either a 3 kDa protein (p3, when in…”
BackgroundAlhawarri, M. B., Al-Thiabat, M. G., Dubey, A., Tufail, A., Fouad, D., Alrimawi, B. H., & Dayoob, M. (2024) · RSC Advances · doi:10.1039/d4ra01070a · Cited by 71
Toward Structural Elucidation of the γ-Secretase Complex
Li, H., Wolfe, M. S., & Selkoe, D. J. (2009) · Structure · doi:10.1016/j.str.2009.01.007 · Cited by 63
AIBP Limits Angiogenesis Through γ-Secretase-Mediated Upregulation of Notch Signaling
Mao, R., Meng, S., Gu, Q., Araujo‐Gutierrez, R., Kumar, S., Yan, Q., Almazan, F., Youker, K. A., Fu, Y., Pownall, H. J., et al. (2017) · Circulation Research · doi:10.1161/circresaha.116.309754 · Cited by 71
Identification of the role of presenilins beyond Alzheimer?s disease
Thinakaran, G., & Parent, A. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2003.12.026 · Cited by 78
Presenilins, Processing of β-Amyloid Precursor Protein, and Notch Signaling
Chan, Y.-M., & Jan, Y. N. (1999) · Neuron · doi:10.1016/s0896-6273(00)80771-0 · Cited by 73
In search of γ-secretase: Presenilin at the cutting edge
Selkoe, D. J., & Wolfe, M. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.11.5690 · Cited by 66
Chong, C.-M., Ke, M., Tan, Y., Huang, Z., Zhang, K., Ai, N., Ge, W., Qin, D., Lu, J.-H., & Su, H. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0945-7 · Cited by 66
A presenilin-1 mutation causes Alzheimer disease without affecting Notch signaling
Zhang, S., Cai, F., Wu, Y., Bozorgmehr, T., Wang, Z., Zhang, S., Huang, D., Guo, J., Shen, L., Rankin, C., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0101-x · Cited by 66
Newman, M., Wilson, L., Verdile, G., Lim, A., Khan, I., Nik, S. H. M., Pursglove, S. E., Chapman, G., Martins, R. N., & Lardelli, M. T. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt448 · Cited by 69
The functional neurophysiology of the amyloid precursor protein (APP) processing pathway
Randall, A. D., Witton, J., Booth, C., Hynes-Allen, A. M., & Brown, J. T. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.02.011 · Cited by 77
Lleó, A., Waldron, E., von Arnim, C. A. F., Herl, L., Tangredi, M. M., Peltan, I. D., Strickland, D. K., Koo, E. H., Hyman, B. T., Pietrzik, C. U., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413969200 · Cited by 67
Saura, C. A., Tomita, T., Soriano, S., Takahashi, M., Leem, J.-Y., Honda, T., Koo, E. H., Iwatsubo, T., & Thinakaran, G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909624199 · Cited by 70
The role of presenilins in Alzheimer’s disease
Thinakaran, G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8728 · Cited by 66
“Lack of PS1 leads to defects in secretion of Aβ peptides and intracellular accumulation of APP CTFs bearing varying extents of the Aβ region (24, 25).”
BackgroundSelkoe, D. J. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(99)00054-9 · Cited by 71
Exploring the Promise of Targeting Ubiquitin-Proteasome System to Combat Alzheimer’s Disease
Mamun, A. A., Uddin, M. S., Kabir, M. T., Khanum, S., Sarwar, M. S., Mathew, B., Rauf, A., Ahmed, M., & Ashraf, G. M. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00185-1 · Cited by 69
Genes and mechanisms involved in β-amyloid generation and Alzheimer's disease
Steiner, H., Capell, A., Leimer, U., & Haass, C. (1999) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s004060050098 · Cited by 83
“These findings are strikingly similar to the effects of a PS1 knockout on Aβ production (De Strooper et al. 1998).”
BackgroundResultThe structure and function of Alzheimer’s gamma secretase enzyme complex
Krishnaswamy, S., Verdile, G., Groth, D. M., Kanyenda, L. J., & Martins, R. N. (2009) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408360903335821 · Cited by 73
Effect of HMG-CoA Reductase Inhibitors on ??-Amyloid Peptide Levels
Höglund, K., & Blennow, K. (2007) · CNS Drugs · doi:10.2165/00023210-200721060-00002 · Cited by 75
Pellegrini, L., Passer, B. J., Canelles, M., Lefterov, I., Ganjei, J. K., Fowlkes, B. J., Koonin, E. V., & D'Adamio, L. (2001) · Journal of Alzheimer's Disease · doi:10.3233/jad-2001-3203 · Cited by 65
“Presenilin-1 and -2 are two highly multipass transmembrane proteins involved in development [33], AβPP and Notch processing [9,10,36,45,47,49], and programmed cell death (PCD) [44,46].”
Marambaud, P., & Robakis, N. K. (2005) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00086.x · Cited by 64
“PS1 deficiency in mammalian cells leads to a defect in APP processing characterized by a decrease of Ab production (De Strooper et al. 1998).”
BackgroundMonocyclic β-Lactams Are Selective, Mechanism-Based Inhibitors of Rhomboid Intramembrane Proteases
Pierrat, O. A., Stříšovský, K., Christova, Y., Large, J. M., Ansell, K. H., Bouloc, N. S., Smiljanic-Hurley, E., & Freeman, M. (2010) · ACS Chemical Biology · doi:10.1021/cb100314y · Cited by 64
Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer’s Disease
Morsy, A., & Trippier, P. C. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01530 · Cited by 70
RIPped out by presenilin-dependent γ-secretase
Medina, M., & Dotti, C. G. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(03)00041-x · Cited by 71
Fujimaki, R., Toyama, Y., Hozumi, N., & Tezuka, K. (2006) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-005-0671-y · Cited by 66
“other than Notch [28–31].”
Jordà‐Siquier, T., Petrel, M., Kouskoff, V., Smailovic, U., Cordelières, F., Frykman, S., Müller, U., Mulle, C., & Barthet, G. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12546 · Cited by 63
Rapamycin promotes β-amyloid production via ADAM-10 inhibition
Zhang, S., Salemi, J., Hou, H., Zhu, Y., Mori, T., Giunta, B., Obregon, D., & Tan, J. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.017 · Cited by 61
“Intramembranously, β-CTF is then cleaved by a multiprotein γ-secretase complex that results in generation of the Aβ peptide and smaller γ-CTF.[25,26] Conversely, in the nonamyloidogenic pathway, APP is first cleaved at the α-secretase site, which results in the release of N-terminal sAPP-α and the generation of α-CTF…”
A Role for SERCA Pumps in the Neurobiology of Neuropsychiatric and Neurodegenerative Disorders
Britzolaki, A., Saurine, J., Klocke, B., & Pitychoutis, P. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12457-1_6 · Cited by 68
Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?
Checler, F., Afram, E., Pardossi-Piquard, R., & Lauritzen, I. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100489 · Cited by 59
“The definitive demonstration that presenilins could be involved in γ-secretase activity came from subsequent functional characterization showing that their depletion fully prevents Aβ production (45, 46).”
BackgroundMoore, C. L., Leatherwood, D. D., Diehl, T. S., Selkoe, D. J., & Wolfe, M. S. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000100f · Cited by 71
Kummer, M. P., Maruyama, H., Huelsmann, C., Baches, S., Weggen, S., & Koo, E. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808904200 · Cited by 60
Wang, J., Brunkan, A. L., Hecimovic, S., Walker, E., & Goate, A. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.008 · Cited by 62
Transgenic animals relevant to Alzheimer’s disease
Seabrook, G. R., & Rosahl, T. W. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(98)00170-1 · Cited by 69
Protease inhibitors as potential disease-modifying therapeutics for Alzheimer’s disease
Beher, D., & Graham, S. L. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.11.1385 · Cited by 67
“•• Demonstrates that PSNs are critically required for γ-secretase activity.”
BackgroundInfluentialMembrane Topology of Alzheimer's Disease-related Presenilin 1
Nakai, T., Yamasaki, A., Sakaguchi, M., Kosaka, K., Mihara, K., Amaya, Y., & Miura, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23647 · Cited by 68
Barão, S., Gärtner, A., Leyva-Díaz, E., Demyanenko, G., Munck, S., Vanhoutvin, T., Zhou, L., Schachner, M., López-Bendito, G., Maness, P. F., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.059 · Cited by 62
“Beta-site amyloid precursor protein-cleaving enzyme 1 (BACE1) and γ-secretase are responsible for the generation of amyloid-beta (Aβ) peptide from Aβ precursor protein (APP) in Alzheimer's disease (AD) (De Strooper et al., 1998; Vassar et al., 1999).”
Colombo, A., Wang, H., Kuhn, P.-H., Page, R., Kremmer, E., Dempsey, P. J., Crawford, H. C., & Lichtenthaler, S. F. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.08.011 · Cited by 62
Sambamurti, K., Greig, N. H., Utsuki, T., Barnwell, E. L., Sharma, E., Mazell, C., Bhat, N. R., Kindy, M. S., Lahiri, D. K., & Pappolla, M. A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07213.x · Cited by 62
“…confirmed when we determined that PS1 antisense RNA reduces PS1 and increases Ab42 while slightly and non-significantly reducing Ab40 (Refolo et al. 1999), and others found that knocking PS1 out results in a complete loss of c-secretase cleavage and Ab40 as well as Ab42 (De Strooper et al. 1998).”
Backgroundp53-Dependent Transcriptional Control of Cellular Prion by Presenilins
Vincent, B., Sunyach, C., Orzechowski, H.-D., St George-Hyslop, P., & Checler, F. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0789-09.2009 · Cited by 56
The molecular link between β- and γ-secretase activity on the amyloid β precursor protein
Tabaton, M., & Tamagno, E. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7219-3 · Cited by 73
Cao, T., Zhou, X., Zheng, X., Cui, Y., Tsien, J. Z., Li, C., & Wang, H. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00137 · Cited by 59
“The malfunction of Presenilins ultimately causes amyloid to accumulate into plaques in the brain (De Strooper et al., 1998).”
BackgroundLee, S. Y., Hwang, D. Y., Kim, Y. K., Lee, J. W., Shin, I. C., Oh, K. W., Lee, M. K., Lim, J. S., Yoon, D. Y., Hwang, S. J., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4017fje;1 · Cited by 60
Wu, G., Hubbard, E. J. A., Kitajewski, J. K., & Greenwald, I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15787 · Cited by 63
Lambert, J.-C., Mann, D. M. A., Harris, J. M., Chartier-Harlin, M.-C., Cumming, A., Coates, J., Lemmon, H., StClair, D., Iwatsubo, T., & Lendon, C. (2001) · Journal of Medical Genetics · doi:10.1136/jmg.38.6.353 · Cited by 61
“expression because of polymorphisms in the promoter may similarly influence the production of Aβ. Indeed, Aβ peptide production can be reduced after inhibition of PS1 expression in cultured cells.”
Backgroundγ-Secretase and the Intramembrane Proteolysis of Notch
Jorissen, E., & Strooper, B. D. (2010) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(10)92006-1 · Cited by 77
“Psen-1 KO mice revealed a Notch phenotype (De Strooper et al., 1999; Shen et al., 1997; Wong et al., 1997) and resulted in a reduced γ-site cleavage of APP (De Strooper et al., 1998).”
Mechanisms of neurodegeneration — Insights from familial Alzheimer’s disease
Chávez-Gutiérrez, L., & Szaruga, M. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2020.03.005 · Cited by 58
Identification of γ-Secretase Inhibitor Potency Determinants on Presenilin
Zhao, B., Yu, M., Neitzel, M., Marugg, J., Jagodzinski, J., Lee, M., Hu, K., Schenk, D., Yednock, T., & Basi, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708870200 · Cited by 62
Grigorenko, A. P., Moliaka, Y. K., Soto, M. C., Mello, C. C., & Rogaev, E. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406462101 · Cited by 67
The Role of Presenilin and its Interacting Proteins in the Biogenesis of Alzheimer’s Beta Amyloid
Verdile, G., Gandy, S. E., & Martins, R. N. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9131-x · Cited by 60
“esis of two highly conserved aspartate residues within transmembrane domains 6 and 7 of PS1 results in a reduction in Ab levels [31–34].”
BackgroundThe Neurobiology and Pharmacotherapy of Alzheimer's Disease
Félician, O., & Sandson, T. A. (1999) · Journal of Neuropsychiatry · doi:10.1176/jnp.11.1.19 · Cited by 70
Alzheimer’s Disease – The Past, the Present and the Future
Botchway, B. O. A., & Iyer, I. C. (2017) · Science Journal of Clinical Medicine · doi:10.11648/j.sjcm.20170601.11 · Cited by 63
“A mutation in the PSEN1 gene causes an inhibition of PSEN1 activity and is a potential target for anti-amyloidogenic therapy in Alzheimer's disease [109].”
BackgroundPhysiological functions of the amyloid precursor protein secretases ADAM10, BACE1, and Presenilin
Prox, J., Rittger, A., & Säftig, P. (2011) · Experimental Brain Research · doi:10.1007/s00221-011-2952-0 · Cited by 69
Substrate ectodomain is critical for substrate preference and inhibition of γ-secretase
Funamoto, S., Sasaki, T., Ishihara, S., Nobuhara, M., Nakano, M., Watanabe-Takahashi, M., Saito, T., Kakuda, N., Miyasaka, T., Nishikawa, K., et al. (2013) · Nature Communications · doi:10.1038/ncomms3529 · Cited by 60
Familial Alzheimer Disease Presenilin-1 Mutations Alter the Active Site Conformation of γ-secretase
Chau, D.-M., Crump, C. J., Villa, J. C., Scheinberg, D. A., & Li, Y.-M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.300483 · Cited by 61
Wang, T., Wang, C.-Y., Shan, Z.-Y., Teng, W.-P., & Wang, Z.-Y. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-111874 · Cited by 59
“The neurotoxic A is generated via cleaving of the -site of A PP and, subsequently, cleaving of the site within the transmembrane domain of A PP protein [50–52].”
BackgroundDavis, J., Wagner, M. R., Zhang, W., Xu, F., & Van Nostrand, W. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301398200 · Cited by 61
Wiley, J. C., Hudson, M. P., Kanning, K. C., Schecterson, L. C., & Bothwell, M. A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03266.x · Cited by 69
“This conclusion was confirmed in experiments employing cells lacking PS1 and PS2, essential components of the c-secretase protease complex (De Strooper et al. 1998; Herreman et al. 2000).”
BackgroundThe link between cholesterol and Alzheimer's disease
Sjögren, M., & Blennow, K. (2005) · The World Journal of Biological Psychiatry · doi:10.1080/15622970510029795 · Cited by 56
“Presenilin-1 seems to be the dominant g-secretase in generating Ab (De Strooper et al. 1998).”
BackgroundLocalization of presenilin–nicastrin complexes and γ‐secretase activity to the trans‐Golgi network
Siman, R., & Velji, J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01616.x · Cited by 49
“…studies demonstrate that PS and nicastrin are required for APP processing and Notch signaling in mammals (Shen et al. 1997; Wong et al. 1997; De Strooper et al. 1998; Herreman et al. 1999; Edbauer et al. 2002; Yu et al. 2000 Zhang et al. 2000), and loss-of-function mutations in orthologous…”
BackgroundTurning the tide on Alzheimer’s disease: modulation of γ-secretase
Luo, J. E., & Li, Y.-M. (2022) · Cell & Bioscience · doi:10.1186/s13578-021-00738-7 · Cited by 59
“PS1 and PS2 mutations were demonstrated to directly affect APP cleavage by γ-secretase and cause toxic gain of function to increase the ratio of Aβ42/Aβ40 [15, 16].”
Backgroundγ-Secretase: a complex target for Alzheimer's disease
Lundkvist, J., & Näslund, J. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.10.002 · Cited by 66
Abnormal blood vessel development in mice lacking presenilin-1
Nakajima, M., Yuasa, S., Ueno, M., Takakura, N., Koseki, H., & Shirasawa, T. (2003) · Mechanisms of Development · doi:10.1016/s0925-4773(03)00064-9 · Cited by 63
“PS1 is suggested to mediate the processing of proteins such as amyloid precursor protein (APP) and Notch-1 (De Strooper et al., 1998,1999; Wolfe et al., 1999).”
BackgroundVetrivel, K. S., Zhang, X., Meckler, X., Cheng, H., Lee, S., Gong, P., Lopes, K. O., Chen, Y., Iwata, N., Yin, K.-J., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801037200 · Cited by 60
Metadata
- Authors
- De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F.
- Affiliations
- Vlaams Instituut voor Biotechnologie (BE)
- University of Göttingen (DE)
- Venue
- Nature
- Published
- 1998-01
- Volume
- 391
- Issue
- 6665
- Pages
- 387-390
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1655404681
- Cited by
- 1,818
- References
- 30
- Citations by year
- 2026: 19 · 2025: 39 · 2024: 47 · 2023: 42 · 2022: 33 · 2021: 35 · 2020: 53 · 2019: 43 · 2018: 36 · 2017: 58 · 2016: 60 · 2015: 43 · 2014: 55 · 2013: 64 · 2012: 71
- FWCI
- 76.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- presenilin 1, amyloid precursor protein, APP processing, gamma-secretase, amyloid-beta 42, Alzheimer's disease, familial Alzheimer's disease, carboxyl-terminal fragment, gain-of-function, membrane proteolysis
- MeSH terms
- Animals, Cells, Cultured, Humans, Membrane Proteins, Neurons, Peptide Fragments, Endopeptidases, Protein Processing, Post-Translational, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, Amyloid beta-Protein Precursor, Point Mutation, Mice, Presenilin-1, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.